Coverage

Latest commissioned research from ABG Sundal Collier

NYAB - ABGSC’s Small & Mid Cap Seminar

Svedbergs Group - Svedbergs saves in Dalstorp

Recent media selection from our coverage

I-tech - Company presentation with CEO Markus Jönsson

Ework Group - Company presentation with CEO Daniel Almgren and CFO Johanna Estra

Byggmästaren - Company presentation with CFO & Deputy CEO Frida Åkerblom

Generic - Company presentation with CEO Hélène Henriksson

Impact Coatings - Company presentation with CEO Jonas Nilsson

PREVIOUS EVENT

Investor Days
21-22 May 2026

CLICK TO VIEW EACH PRESENTATION

Acconeer	Inission
AlzeCure Pharma	Isofol Medical
Ascelia Pharma	I-tech
B3 Consulting Group	Karnell
BTS Group	Linc
Byggmästaren	Lumi Gruppen
ByggPartnerGruppen	Midsona

Cinclus Pharma	Momentum Group
Coeli Private Equity	Oncopeptides
CTEK	Orexo
Donkey Republic	Prevas
Eastnine	Proact IT Group

Eltel	Qben Infra
Embellence Group	Qliro
Enity	SinterCast
Eolus	Skolon
ES Energy Save	SmartCraft

Ferronordic	Stenhus Fastigheter
Generic	StrongPoint
Genova Property Group	Svedbergs Group
Haypp Group	Tempest Security
Impact Coatings	WS WESports Group

Infrea	4C Group

Latest company news

About ABGSC

Enabling businesses and capital to grow and perform ABG Sundal Collier is founded on an inclusive partnership culture and the ability to attract and develop top talent. The merger between Norwegian Sundal Collier and Swedish ABG in 2001 laid the foundation for today’s independent, full-service investment bank. We have a strong Nordic heritage, with operations in Norway, Sweden and Denmark and a global reach through our sales offices in Frankfurt, London, New York and Singapore. Relying on our superior transaction experience and network, we advise and guide clients when acquiring, consolidating or selling assets. With our outstanding investor access and placing power, we help corporations and entrepreneurs to finance their businesses. Through our highquality research, we enable smarter investment decisions. We are committed to excellence, and offer deep sector knowledge, extensive transaction experience and access to a large network of corporates and investors. We take great pride in always delivering first-class service, and we always seek to obtain a high degree of client satisfaction.

PAST EVENT

Investor Days
3-4 December 2025

CLICK TO VIEW PRESENTATION

Acconeer	Inission
Ascelia Pharma	INVISIO
B3 Consulting Group	Isofol Medical
Bergman & Beving	I-Tech
BTS Group	Lumi Gruppen
Byggmästaren	Meds Apotek
C-RAD	Midsona

Catella	Nexam Chemical
Cavotec	Nilörn
CDON	NYAB
Clavister	OrganoClick
Done.AI	OssDsign

Eastnine	Ovzon
Eltel	poLight
Embellence Group	Prevas
Eolus	Proact IT Group
Ework Group	SinterCast

Ferronordic	Skolon
G5 Entertainment	Stenhus Fastigheter
Gentoo Media	StrongPoint
Green Landscaping Gr.	Studsvik
Humble Group	Svedbergs Group

Impact Coatings	Tempest Security
Infrea	Viscaria
	Xplora Technologies

Past event

ABGSC INVESTOR DAYS 21-22 May
Hotel At Six @ Brunkebergstorg 6 Stockholm

You are invited to ABGSC Investor Days which provides an opportunity for investors to learn more about some of the companies covered by ABG Sundal Collier’s sponsored research (cr.abgsc.com) and a few selected up-and-coming companies with innovative business models.
Language: Most of the presentations will be in Swedish

SEE ALL PRESENTATIONS LIVE:
21/5 08:45-16:25 CEST
Go to Track 1: https://youtube.com/live/viQQZNevUFI
Go to Track 2: https://youtube.com/live/LJErEmXxBZU

22/5 08:45-14:40 CEST
Go to Track 1: https://youtube.com/live/ngjwdljpdk0
Go to Track 2: https://youtube.com/live/SilpWTDq1I8

>>>CLICK HERE FOR SCHEDULE<<<

Press the button and be introduced to a new random company!

Social media

Latest commissioned research from ABG Sundal Collier

NYAB - ABGSC’s Small & Mid Cap Seminar

Svedbergs Group - Svedbergs saves in Dalstorp

Proact - Meeting with the CEO

Recent media selection from our coverage

Infrea

Infrea - Fireside Chat with CEO Martin Reinholdsson

New company at ABGSC - Nepa

Byggmästaren

Byggmästaren - Q2 Earnings Call with CEO Tomas Bergström

New milestone for AlzeCure Pharma — Two major licensing deals in a month

New company at ABGSC - Qliro